We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YYGH:NASDAQYY Group Holding Limited Analysis

Data as of 2026-05-12 - not real-time

$1.06

Latest Price

8/10Risk

Risk Level: High

Executive Summary

YY Group Holding is trading well below its 20‑day and 50‑day simple moving averages, with the 200‑day average sitting far higher, indicating a pronounced bearish price bias. The RSI sits in the mid‑30s, suggesting the stock may be oversold, while the MACD line has crossed above the signal line, providing a modest bullish signal amid the overall downtrend. Volume has been increasing, offering some liquidity support, and the company recently secured a contract exceeding SGD 5 million, bolstering recurring revenue and diversifying its integrated facilities management client base. Revenue grew sharply year‑over‑year, and the firm regained compliance with Nasdaq’s minimum bid price requirement, addressing a key listing risk. However, earnings remain deeply negative, margins are in the red, and free cash flow, while positive, is modest relative to the scale of operations. The discounted cash flow model projects a fair value dramatically higher than the current market price, and the price‑to‑book ratio reflects a deep discount to book value. The market sentiment index shows “Extreme Greed,” indicating that broader investor appetite may be inflating speculative interest despite the fundamentals.
Given the high beta and extreme 30‑day volatility, coupled with a historic maximum drawdown approaching total loss, the stock carries substantial risk. The lack of dividend and thin analyst coverage further limit defensive attributes. Nevertheless, the combination of strong top‑line growth, strategic contract wins, and a valuation gap suggests that patient investors could capture significant upside if the company can turn around profitability and sustain its growth trajectory.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price deep below short‑term moving averages
  • negative earnings and operating margins
  • elevated volatility and beta

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • rapid revenue growth and new high‑value contracts
  • continued compliance with Nasdaq listing standards
  • persistent valuation discount to book and DCF

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicates substantial upside
  • price‑to‑book ratio shows deep discount
  • strategic expansion of recurring revenue streams

Key Metrics & Analysis

Financial Health

Revenue Growth44.20%
Profit Margin-37.42%
ROE-217.97%
ROA-35.42%
Debt/Equity59.06
P/B Ratio0.1
Op. Cash Flow$-1958742
Free Cash Flow$2.7M

Technical Analysis

TrendBearish
RSI35.1
Support$0.70
Resistance$1.70
MA 20$1.27
MA 50$2.19
MA 200$25.38
MACDBullish
VolumeIncreasing
Fear & Greed Index87.93

Valuation

Fair Value$21.64
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.49
Volatility157.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.